Monday, November 19, 2018

Nature Chemical Biology Contents: December 2018, Volume 14 No 12

Nature Chemical Biology


Advertisement
Discover the LOPAC®1280 small molecule library. 

The power and performance of our Library of Pharmacologically Active Compounds is assured.

  • 1,280 pharmacologically active compounds
  • Ready-to-use DMSO stocks: less time-consuming sample preparation
  • Highly pure compounds with full QC: re-supply as individual catalog items
Learn More
TABLE OF CONTENTS

December 2018 Volume 14, Issue 12

Research Highlights
News & Views
Articles

Research Highlights

Failure to convert    p1067
Grant Miura
doi:10.1038/s41589-018-0172-7

Metal Enterococcus equipment    p1067
Mirella Bucci
doi:10.1038/s41589-018-0173-6

Transcriptional recorder    p1067
Yiyun Song
doi:10.1038/s41589-018-0174-5

Devilish diatoms    p1067
Caitlin Deane
doi:10.1038/s41589-018-0175-4

Nature Chemical Biology
EVENT
6th Nucleic Acids Conference
12.02.19
Nassau, Bahamas
More science events from

News & Views

The splice is right    pp1068 - 1069
James Palacino
doi:10.1038/s41589-018-0147-8

Expanding the terpenoid kingdom    pp1069 - 1070
Yongjin J. Zhou
doi:10.1038/s41589-018-0167-4

Divining sugar substrates    pp1071 - 1072
Jochen Schmid
doi:10.1038/s41589-018-0165-6

Advertisement
Do you have a career question? 

The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud. 

Listen today!
 

Articles

Small molecules that target group II introns are potent antifungal agents    pp1073 - 1078
Olga Fedorova, G. Erik Jagdmann Jr., Rebecca L. Adams, Lin Yuan, Michael C. Van Zandt et al.
doi:10.1038/s41589-018-0142-0

High-throughput screening followed by an examination of structure–activity relationship-based optimization resulted in the identification of potent small-molecule inhibitors of group IIB intron splicing in fungal organisms.

Disrupting the CD95–PLCγ1 interaction prevents Th17-driven inflammation    pp1079 - 1089
Amanda Poissonnier, Jean-Philippe Guégan, Ha Thanh Nguyen, Daniel Best, Nicolas Levoin et al.
doi:10.1038/s41589-018-0162-9

The HIV protease inhibitor ritonavir targets the calcium-inducing domain (CID) of CD95 to block interactions with PLCγ1. Peptidomimetics targeting the CD95 CID prevents accumulation of inflammatory Th17 cells observed in systemic lupus erythematosus.

Synthesis of 11-carbon terpenoids in yeast using protein and metabolic engineering    pp1090 - 1098
Codruta Ignea, Marianna Pontini, Mohammed S. Motawia, Massimo E. Maffei, Antonios M. Makris et al.
doi:10.1038/s41589-018-0166-5

Yeast engineered to produce the six-carbon terpene building block 2-methyl-geranyl diphosphate, coupled with terpene synthases engineered to accept this noncanonical substrate, enables the biosynthesis of a collection of new C11 terpenoid scaffolds.

Selective blockade of the lyso-PS lipase ABHD12 stimulates immune responses in vivo    pp1099 - 1108
Daisuke Ogasawara, Taka-Aki Ichu, Vincent F. Vartabedian, Jacqueline Benthuysen, Hui Jing et al.
doi:10.1038/s41589-018-0155-8

High-throughput screening and activity-based protein profiling find a selective and in vivo–active inhibitor of the membrane-associated serine hydrolase ABHD12 that alters lysophospholipid content and has immunostimulatory effects.

Functional and informatics analysis enables glycosyltransferase activity prediction    pp1109 - 1117
Min Yang, Charlie Fehl, Karen V. Lees, Eng-Kiat Lim, Wendy A. Offen et al.
doi:10.1038/s41589-018-0154-9

Bioinformatic analysis coupled to substrate-reactivity profiling for the glycosyltransferase (GT) enzyme superfamily supports the development of 'GT-Predict' as a tool for functional prediction of GT–substrate relationships.

Identification of a cellularly active SIRT6 allosteric activator    pp1118 - 1126
Zhimin Huang, Junxing Zhao, Wei Deng, Yingyi Chen, Jialin Shang et al.
doi:10.1038/s41589-018-0150-0

The use of an allosteric drug-design method resulted in the identification of a first-in-class cellularly active SIRT6 activator that induces cell-cycle arrest in the G0–G1 phase, thus suppressing proliferation in human hepatocellular carcinoma cells.

The multicatalytic compartment of propionyl-CoA synthase sequesters a toxic metabolite    pp1127 - 1132
Iria Bernhardsgrütter, Bastian Vögeli, Tristan Wagner, Dominik M. Peter, Niña Socorro Cortina et al.
doi:10.1038/s41589-018-0153-x

Structural and biochemical analysis of propionyl-CoA synthase reveals that it forms a reaction chamber containing three active sites, which sequesters the reactive intermediate acrylyl-CoA during the conversion of 3-hydroxypropionate to propionyl-CoA.

Identification of Chaoborus kairomone chemicals that induce defences in Daphnia    pp1133 - 1139
Linda C. Weiss, Bauke Albada, Sina M. Becker, Sven W. Meckelmann, Julia Klein et al.
doi:10.1038/s41589-018-0164-7

The freshwater microcrustacean Daphnia pulex forms defensive neckteeth in response to a collection of chemical cues (the kairomone), now identified as certain fatty acids conjugated to glutamine, released during digestion by its predator Chaoborus.

Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking    pp1140 - 1149
Xin Li, Xiao-Meng Li, Yixiang Jiang, Zheng Liu, Yiwen Cui et al.
doi:10.1038/s41589-018-0144-y

An inhibitor of the YEATS domain was developed by targeting a unique π-π-π stacking in the YEATS–Kcr recognition. An ENL YEATS-selective inhibitor, XL-13m, helps probe the YEATS-dependent role of ENL in the leukemogenic transcription program.

Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor    pp1150 - 1158
Ryoji Suno, Sangbae Lee, Shoji Maeda, Satoshi Yasuda, Keitaro Yamashita et al.
doi:10.1038/s41589-018-0152-y

A structural study supported by molecular dynamics simulations describes the basis of receptor-subtype selectivity of a small-molecule antagonist of the human muscarinic M2 receptor.

Advertisement
Searching for a new career?

At Nature Research we frequently recruit talented individuals to join our editorial and publishing teams. If you have a PhD and a passion for science this may be the perfect career for you.

Visit our research editorial and publishing careers website to discover more about what we do.
 
Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

This email has been sent to edgeblog.alerts.2011.001@gmail.com.

If you no longer wish to receive the email alerts from Nature Chemical Biology click here to unsubscribe .
If you wish to discontinue all email services from Nature Research please click here to unsubscribe .

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature

No comments: